Changes to the Datwyler Board of Directors
Nomination of Judith van Walsum and resignation of Hanno Ulmer.
Datwyler shortlisted for Pharmaceutical Technology's Environmental Impact Award
The Environmental Impact Award was given to Alliance-to-Zero.
Datwyler is accelerating growth in the Chinese healthcare market
By taking over the Chinese company Yantai Xinhui Packing, Datwyler will gain direct access to the rapidly growing healthcare market in China.
Datwyler makes its debut at FCE Pharma with high-quality, system-critical components for vaccine providers
Datwyler meets demand for injectable drug packaging components for COVID-19 vaccine providers and also pioneered its StarterPack™.
Datwyler named as one of the best Swiss employers
At the 21st Swiss Employer Awards, the Swiss Datwyler site in Schattdorf was awarded fourth place among medium-sized companies.
Datwyler enhances material capabilities in China
Production of Liquid Silicone Rubber components to begin in Wuxi in early 2022.
Drug Delivery Devices for Net Zero Emissions: A Pharma Supply Chain Collaboration
For the pharmaceutical industry, the reduction of carbon emissions requires urgent action to meet global sustainability goals. (Recording available)
Datwyler showcases its StarterPack™ at CPhI Worldwide.
The ready-to-use packaging system helps drug developers minimize time to market while putting quality first.
Datwyler with gain on sale of Reichelt.
Following the deconsolidation of Reichelt and the related companies, a gain on sale of subsidiaries of some CHF 58 million is credited to income.
Datwyler completes the sale of Reichelt.
Datwyler has completed the announced sale of online distributor Reichelt as of 29 September 2021. The antitrust authorities approved the transaction without imposing any restrictions.
Datwyler invests in profitable growth.
Datwyler is expanding its production capacity with targeted investments and laying the foundation for further profitable growth.